E. Hirsch and S. Hunot, Neuroinflammation in Parkinson's disease: a target for neuroprotection?, The Lancet Neurology, vol.8, issue.4, pp.382-397, 2009.
DOI : 10.1016/S1474-4422(09)70062-6

G. Liberatore, V. Jackson-lewis, S. Vukosavic, A. Mandir, M. Vila et al., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat Med, vol.5, pp.1403-1409, 1999.

D. Wu, P. Teismann, K. Tieu, M. Vila, V. Jackson-lewis et al., NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.100, issue.10, pp.6145-6150, 2003.
DOI : 10.1073/pnas.0937239100

Z. Pei, H. Pang, L. Qian, S. Yang, T. Wang et al., MAC1 mediates LPS-induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity, Glia, vol.170, issue.13, pp.259-277, 2007.
DOI : 10.1002/glia.20545

X. Hu, D. Zhang, H. Pang, W. Caudle, Y. Li et al., Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease, The Journal of Immunology, vol.181, issue.10, pp.7194-7204, 2008.
DOI : 10.4049/jimmunol.181.10.7194

C. Nathan, S. Srimal, C. Farber, E. Sanchez, L. Kabbash et al., Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins, The Journal of Cell Biology, vol.109, issue.3, pp.1341-1349, 1989.
DOI : 10.1083/jcb.109.3.1341

C. Abram and C. Lowell, The Expanding Role for ITAM-Based Signaling Pathways in Immune Cells, Science's STKE, vol.2007, issue.377, p.2, 2007.
DOI : 10.1126/stke.3772007re2

A. Mócsai, C. Abram, Z. Jakus, Y. Hu, L. Lanier et al., Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs, Nature Immunology, vol.54, issue.12, pp.1326-1333, 2006.
DOI : 10.1074/jbc.M311618200

S. Wakselman, C. Béchade, A. Roumier, D. Bernard, A. Triller et al., Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor, Journal of Neuroscience, vol.28, issue.32, pp.8138-8143, 2008.
DOI : 10.1523/JNEUROSCI.1006-08.2008

J. Satoh, H. Tabunoki, T. Ishida, S. Yagishita, K. Jinnai et al., Immunohistochemical characterization of microglia in Nasu-Hakola disease brains, Neuropathology, vol.105, issue.1, pp.363-375, 2011.
DOI : 10.1111/j.1440-1789.2010.01174.x

A. Roumier, C. Béchade, J. Poncer, K. Smalla, E. Tomasello et al., Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse, Journal of Neuroscience, vol.24, issue.50, pp.11421-11428, 2004.
DOI : 10.1523/JNEUROSCI.2251-04.2004

E. Tomasello, P. Desmoulins, K. Chemin, S. Guia, H. Cremer et al., Combined Natural Killer Cell and Dendritic Cell Functional Deficiency in KARAP/DAP12 Loss-of-Function Mutant Mice, Immunity, vol.13, issue.3, pp.355-364, 2000.
DOI : 10.1016/S1074-7613(00)00035-2

S. Guerreiro, D. Toulorge, E. Hirsch, M. Marien, P. Sokoloff et al., Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels, Molecular Pharmacology, vol.74, issue.4, pp.980-989, 2008.
DOI : 10.1124/mol.108.048207

C. Théry, B. Chamak, and M. Mallat, Cytotoxic Effect of Brain Macrophages on Developing Neurons, European Journal of Neuroscience, vol.174, issue.11, pp.1155-1164, 1991.
DOI : 10.1016/0006-8993(89)91550-3

T. Nolan, R. Hands, and S. Bustin, Quantification of mRNA using real-time RT-PCR, Nature Protocols, vol.113, issue.3, pp.1559-1582, 2006.
DOI : 10.1038/nprot.2006.236

A. Luster, R. Alon, and U. Von-andrian, Immune cell migration in inflammation: present and future therapeutic targets, Nature Immunology, vol.23, issue.12, pp.1182-1190, 2005.
DOI : 10.1038/ni1275

W. Zhang, L. Qin, T. Wang, S. Wei, H. Gao et al., 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity, The FASEB Journal, vol.19, pp.395-397, 2005.
DOI : 10.1096/fj.04-1586fje

K. Beck, B. Knusel, G. Pasinetti, P. Michel, H. Zawadzka et al., Tyrosine Hydroxylase mRNA Expression by Dopaminergic Neurons in Culture: Effect of 1 -Methyl-4-Phenylpyridinium Treatment, Journal of Neurochemistry, vol.46, issue.2, pp.527-532, 1991.
DOI : 10.1016/0304-3940(86)90083-2

V. Bindokas, J. Jordán, C. Lee, and R. Miller, Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine, J Neurosci, vol.16, pp.1324-1336, 1996.

W. Dauer and S. Przedborski, Parkinson's Disease, Neuron, vol.39, issue.6, pp.889-909, 2003.
DOI : 10.1016/S0896-6273(03)00568-3

J. Marín-teva, I. Dusart, C. C. Gervais, A. Van-rooijen, N. Mallat et al., Microglia Promote the Death of Developing Purkinje Cells, Neuron, vol.41, issue.4, pp.535-547, 2004.
DOI : 10.1016/S0896-6273(04)00069-8

M. Mallat, J. Marín-teva, and C. Chéret, Phagocytosis in the developing CNS: more than clearing the corpses, Current Opinion in Neurobiology, vol.15, issue.1, pp.101-107, 2005.
DOI : 10.1016/j.conb.2005.01.006

G. Sessa, P. Podini, M. Mariani, A. Meroni, R. Spreafico et al., Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia, European Journal of Neuroscience, vol.57, issue.10, pp.2617-2628, 2004.
DOI : 10.1016/S0920-1211(98)00038-2

N. Laflamme and S. Rivest, Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components, The FASEB Journal, vol.15, issue.1, pp.155-163, 2001.
DOI : 10.1096/fj.00-0339com

H. Kanzler, F. Barrat, E. Hessel, and R. Coffman, Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists, Nature Medicine, vol.26, issue.5, pp.552-559, 2007.
DOI : 10.1038/nm1589

S. Lehnardt, E. Schott, T. Trimbuch, D. Laubisch, C. Krueger et al., A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS, Journal of Neuroscience, vol.28, issue.10, pp.2320-2331, 2008.
DOI : 10.1523/JNEUROSCI.4760-07.2008

L. Stefano, G. Racchetti, F. Bianco, N. Passini, R. Gupta et al., The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor, Journal of Neurochemistry, vol.174, issue.1, pp.284-294, 2009.
DOI : 10.1111/j.1471-4159.2009.06130.x

J. Hamerman, N. Tchao, C. Lowell, and L. Lanier, Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12, Nature Immunology, vol.19, issue.6, pp.579-586, 2005.
DOI : 10.1016/S0022-1759(98)00204-X

J. Hamerman, J. Jarjoura, M. Humphrey, M. Nakamura, W. Seaman et al., Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP12, The Journal of Immunology, vol.177, issue.4, pp.2051-2055, 2006.
DOI : 10.4049/jimmunol.177.4.2051